Evaxion Biotech Stock (NASDAQ:EVAX)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$1.54

52W Range

$1.28 - $13.61

50D Avg

$2.72

200D Avg

$3.23

Market Cap

$7.92M

Avg Vol (3M)

$52.25K

Beta

-0.23

Div Yield

-

EVAX Company Profile


Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Phase IIa trial for adjuvant melanoma; and EVX-03, a DNA-based immunotherapy for the treatment of various cancers. Its programs also include EVX-B1, EVX-B2, and EVX-V1, which are vaccines that are in pre-clinical stage for the treatment of bacterial and viral diseases. The company was incorporated in 2008 and is headquartered in Hørsholm, Denmark.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

Yes

Country

DK

Employees

49

IPO Date

Feb 05, 2021

Website

EVAX Performance


EVAX Financial Summary


Dec 23Dec 22Dec 21
Revenue$73.11K--
Operating Income$-22.23M$-25.26M$-25.83M
Net Income$-22.16M$-23.17M$-24.53M
EBITDA$-21.62M$-22.43M$-23.80M
Basic EPS$-8.11$-9.80$-12.58
Diluted EPS$-8.11$-9.80$-12.58

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 14, 24 | 11:43 AM
Q4 23Apr 02, 24 | 2:10 PM
Q2 23Aug 22, 23 | 5:34 PM

Peer Comparison


TickerCompany
ZVSAZyVersa Therapeutics, Inc.
BDRXBiodexa Pharmaceuticals Plc
CGEMCullinan Oncology, Inc.
RVMDRevolution Medicines, Inc. Warrant
RVPHReviva Pharmaceuticals Holdings, Inc.
PHIOPhio Pharmaceuticals Corp.
REVBRevelation Biosciences, Inc.
QNRXQuoin Pharmaceuticals, Ltd.
RNAZTransCode Therapeutics, Inc.
LABPLandos Biopharma, Inc.
LYELLyell Immunopharma, Inc.
SGTXSigilon Therapeutics, Inc.
VRAXVirax Biolabs Group Limited
EFTReFFECTOR Therapeutics, Inc.
ALLRAllarity Therapeutics, Inc.
GLUEMonte Rosa Therapeutics, Inc.
UNCYUnicycive Therapeutics, Inc.
ZURAZura Bio Limited